Business
Cristian Massacesi, M.D., Joins Bristol Myers Squibb as Executive Vice President, Chief Medical Officer and Head of Development
PRINCETON, N.J., July 25, 2025--Cristian Massacesi, M.D., Joins Bristol Myers Squibb as Executive Vice President, Chief Medical Officer and Head of Development
About this update from Bristol-myers Squibb Company
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1497,"height":206,"url":"https://media.zenfs.com/en/business-wire.com/3fcaa71fc3c8a1d6398e50cdb652979b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XwM9_Q9oIj.Dcb62.T.ObQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEzMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/3fcaa71fc3c8a1d6398e50cdb652979b","width":960,"height":132},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/vJ5ltW78mRXeY6qt0ThUQA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zMzA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/3fcaa71fc3c8a1d6398e50cdb652979b","width":1200,"height":165}},"lazy":false},{"type":"text","content":"Dr. Massacesi will join BMS August 1 and serve on the Executive Leadership Team","length":79,"tagName":"p","attribs":{}},{"type":"text","content":"Samit Hirawat, M.D., Executive Vice President, to step down from his role on August 1 and will depart BMS on November 1","length":119,"tagName":"p","attribs":{}},{"type":"text","content":"PRINCETON, N.J., July 25, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cristian Massacesi, M.D., as Executive Vice President, Chief Medical Officer, and Head of Development, effective August 1, 2025. In this role, Dr. Massacesi will oversee the company’s early-stage and late-stage product development across all therapeutic areas.","length":377,"tagName":"p"},{"type":"text","content":""We are thrilled to welcome Cristian to Bristol Myers Squibb," said Christopher Boerner, Ph.D., board chair and chief executive officer, Bristol Myers Squibb. "His deep scientific expertise, strong focus on clinical execution and proven track record of regulatory approvals will be instrumental as we continue to advance our pipeline and deliver breakthrough medicines to even more patients around the world. Cristian also has a very strong track record of building and developing world-class teams."","length":520,"tagName":"p"},{"type":"text","content":""I am on a mission to discover new medicines - unlocking innovative approaches to researching and treating challenging diseases so that one day, no patient will hear that all options have been exhausted. I am excited to join BMS in this shared purpose, with its storied history...